PROCEPT BioRobotics Corporation (PRCT) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$25.40M*; Operating income -$27.39M; Depreciation and amortization $1.99M*.
- 2026-03-31: Basis Reported; EBITDA -$30.87M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$29.33M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$21.57M*; Operating income -$23.19M; Depreciation and amortization $1.62M*.
Complete source-backed ebitda history.
- Available history
- 2020-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$25.40M* | -$27.39M | $1.99M* | $94.50M | -26.88%* | $2.95M* | -$19.25M* | (m) | $20.10M | $69.67M | $94.00K |
|---|
| 2026-03-31 | Reported | -$30.87M | (m) | (m) | (m) | -37.13% | $2.91M | -$38.13M | (m) | $21.46M | $65.09M | -$43.00K |
|---|
| 2025-12-31 | Reported | -$29.33M | (m) | (m) | (m) | -38.40% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$21.57M* | -$23.19M | $1.62M* | $83.33M | -25.89%* | $2.87M* | -$6.63M* | (m) | $18.19M | $59.01M | (m) |
|---|
| 2025-06-30 | Reported | -$20.60M* | -$22.19M | $1.59M* | $79.18M | -26.02%* | $2.80M* | -$15.04M* | (m) | $17.63M | $56.30M | $136.00K |
|---|
| 2025-03-31 | Reported | -$25.96M | (m) | (m) | (m) | -37.54% | $1.84M | -$16.98M | (m) | $16.40M | $55.20M | -$47.00K |
|---|
| 2024-12-31 | Reported | -$18.26M | (m) | (m) | (m) | -26.76% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$21.10M* | -$22.43M | $1.33M* | $58.37M | -36.15%* | $246.00K* | -$18.80M* | (m) | $16.65M | $42.69M | (m) |
|---|
| 2024-06-30 | Reported | -$25.56M* | -$26.83M | $1.27M* | $53.35M | -47.91%* | $1.04M* | -$15.74M* | (m) | $17.50M | $40.81M | (m) |
|---|
| 2024-03-31 | Reported | -$26.47M | (m) | (m) | (m) | -59.42% | $1.95M | -$32.29M | (m) | $13.08M | $39.60M | (m) |
|---|
| 2023-12-31 | Reported | -$28.24M | (m) | (m) | (m) | -64.80% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$24.55M* | -$25.61M | $1.05M* | $35.10M | -69.95%* | $5.78M* | -$18.94M* | (m) | $11.60M | $32.88M | (m) |
|---|
| 2023-06-30 | Reported | -$24.98M* | -$25.63M | $642.00K* | $33.10M | -75.47%* | $5.37M* | -$28.34M* | (m) | $11.61M | $32.44M | (m) |
|---|
| 2023-03-31 | Reported | -$27.58M | (m) | (m) | (m) | -113.03% | $5.34M | -$35.93M | (m) | $10.74M | $30.13M | (m) |
|---|
| 2022-12-31 | Reported | -$24.38M | (m) | (m) | (m) | -102.52% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$21.40M* | -$22.11M | $703.00K* | $20.35M | -105.17%* | $1.51M* | -$19.85M* | (m) | $7.58M | $24.75M | (m) |
|---|
| 2022-06-30 | Reported | -$17.16M* | -$17.88M | $717.00K* | $16.69M | -102.80%* | $218.00K* | -$17.13M* | (m) | $6.71M | $19.66M | (m) |
|---|
| 2022-03-31 | Reported | -$14.95M | (m) | (m) | (m) | -105.28% | $55.00K | -$18.23M | (m) | $5.01M | $18.39M | (m) |
|---|
| 2021-12-31 | Reported | -$16.07M | (m) | (m) | (m) | -158.49% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$12.00M* | -$12.80M | $796.00K* | $8.67M | -138.45%* | $111.00K* | -$12.75M* | (m) | $4.92M | $12.12M | (m) |
|---|
| 2021-06-30 | Reported | -$12.34M* | -$13.19M | $850.00K* | $8.48M | -145.61%* | $110.00K* | -$12.91M* | (m) | $4.48M | $12.30M | (m) |
|---|
| 2021-03-31 | Reported | -$10.43M | (m) | (m) | (m) | -145.01% | $39.00K | -$15.20M | (m) | $4.52M | $10.35M | (m) |
|---|
| 2020-12-31 | Reported | -$12.49M | (m) | (m) | (m) | -387.83% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$10.98M | (m) | $2.11M | (m) | (m) | (m) | (m) | $3.89M | $7.05M | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$97.47M | (m) | (m) | (m) | -31.64% | $9.36M | -$48.98M | (m) | $71.28M | $228.81M | $190.00K |
|---|
| 2024-12-31 | Reported | -$91.38M | (m) | (m) | (m) | -40.70% | $4.41M | -$99.21M | (m) | $62.30M | $171.41M | $368.00K |
|---|
| 2023-12-31 | Reported | -$105.36M | (m) | (m) | (m) | -77.36% | $25.21M | -$108.00M | (m) | $48.45M | $131.77M | $80.00K |
|---|
| 2022-12-31 | Reported | -$77.88M | (m) | (m) | (m) | -103.82% | $2.65M | -$80.38M | (m) | $28.98M | $88.83M | $0.00 |
|---|
| 2021-12-31 | Reported | -$50.84M | (m) | (m) | (m) | -147.48% | $592.00K | -$57.33M | (m) | $18.99M | $51.04M | $0.00 |
|---|
| 2020-12-31 | Reported | -$44.94M | (m) | (m) | (m) | -582.38% | $233.00K | -$48.34M | (m) | $16.27M | $30.27M | $0.00 |
|---|